| [Latest] Global Laboratory Informatics Market Size/Share Worth USD 8.21 Billion by 2035 at a 5.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) |
Globe Newswire |
02/26 |
07:30 |
| FTI Consulting Reports Fourth Quarter and Full Year 2025 Financial Results |
Globe Newswire |
02/26 |
07:30 |
| U.S. Dental Insurance Market Size to Surpass USD 126.5 Billion by 2035 |
Globe Newswire |
02/26 |
07:27 |
| Exodus Movement, Inc. to Announce Fourth Quarter and Full Year 2025 Results on March 11, 2026 |
Globe Newswire |
02/26 |
07:20 |
| UK-China talks on Thermobalancing therapy for kidney stones, enlarged/inflamed prostate, back pain and joints problems |
Globe Newswire |
02/26 |
07:13 |
| Conavi Medical Reports Fiscal First Quarter 2026 Results and Operational Highlights |
Globe Newswire |
02/26 |
07:05 |
| Boehringer Ingelheim licenses novel oral therapeutics program for immune diseases from Sitryx Therapeutics |
Globe Newswire |
02/26 |
07:05 |
| Gilat Demonstrates 5G NTN End-to-End Connectivity over GEO Satellite |
Globe Newswire |
02/26 |
07:04 |
| Ligand Reports Fourth Quarter and Full Year 2025 Financial Results |
Globe Newswire |
02/26 |
07:00 |
| Kymera Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update |
Globe Newswire |
02/26 |
07:00 |
| ACM Research Receives Multiple Advanced Packaging Equipment Orders from Leading Global Customers |
Globe Newswire |
02/26 |
07:00 |
| Boehringer Ingelheim licenses novel oral therapeutics program for immune diseases from Sitryx Therapeutics |
Globe Newswire |
02/26 |
07:00 |
| C4 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights |
Globe Newswire |
02/26 |
07:00 |
| Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results |
Globe Newswire |
02/26 |
07:00 |
| Luckin Coffee Announces Fourth Quarter and Fiscal Year 2025 Financial Results |
Globe Newswire |
02/26 |
07:00 |
| ACM Research Reports Fourth Quarter and Fiscal Year 2025 Results |
Globe Newswire |
02/26 |
07:00 |
| Aeluma to Participate in 38th Annual ROTH Conference |
Globe Newswire |
02/26 |
07:00 |
| Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update |
Globe Newswire |
02/26 |
07:00 |
| TScan Therapeutics Completes Enrollment in Cohort C of Phase 1 ALLOHA™ Trial and Announces FDA Clearance of Investigational New Drug Applications for Heme Candidates TSC-102-A01 and TSC-102-A03 |
Globe Newswire |
02/26 |
07:00 |
| Amphista Therapeutics presents new data demonstrating how its advanced Eclipsys® platform is delivering Targeted Glue™ degraders using novel E3 ligases into the clinic |
Globe Newswire |
02/26 |
07:00 |
| PyroGenesis Confirms Successful Primary Test Campaign with Leading Battery Recycler |
Globe Newswire |
02/26 |
07:00 |
| Calian and ADGA Group Sign Collaborative Agreement to Advance Next-Generation Land Training and Simulation for the Canadian Army |
Globe Newswire |
02/26 |
07:00 |
| Liquidia Corporation to Report Full Year 2025 Financial Results on March 5, 2026 |
Globe Newswire |
02/26 |
07:00 |
| GigaCloud Technology Inc Announces Fourth Quarter and Year Ended December 31, 2025 Financial Results |
Globe Newswire |
02/26 |
07:00 |
| Juvenescence successfully completes Phase 1 clinical trial of PAI-1 inhibitor and strengthens clinical development leadership |
Globe Newswire |
02/26 |
07:00 |
